138.90
전일 마감가:
$141.06
열려 있는:
$142.05
하루 거래량:
1.20M
Relative Volume:
0.95
시가총액:
$18.97B
수익:
$1.53B
순이익/손실:
$-214.69M
주가수익비율:
-78.92
EPS:
-1.76
순현금흐름:
$-43.68M
1주 성능:
+0.00%
1개월 성능:
-15.39%
6개월 성능:
-17.13%
1년 성능:
+35.98%
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NTRA
Natera Inc
|
138.90 | 19.26B | 1.53B | -214.69M | -43.68M | -1.76 |
![]()
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
![]()
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
2025-01-23 | 개시 | Barclays | Overweight |
2024-06-03 | 재개 | Jefferies | Buy |
2024-04-08 | 재개 | Craig Hallum | Buy |
2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2023-12-29 | 재확인 | BTIG Research | Buy |
2023-12-14 | 개시 | Guggenheim | Buy |
2023-12-13 | 개시 | Wolfe Research | Outperform |
2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2023-09-28 | 개시 | Bernstein | Mkt Perform |
2023-07-05 | 재개 | JP Morgan | Overweight |
2023-05-05 | 개시 | UBS | Buy |
2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2022-08-25 | 개시 | Credit Suisse | Outperform |
2022-04-25 | 개시 | Stephens | Overweight |
2022-03-08 | 개시 | Goldman | Buy |
2022-01-06 | 재개 | Piper Sandler | Overweight |
2021-10-15 | 재개 | Cowen | Outperform |
2021-06-15 | 개시 | Raymond James | Mkt Perform |
2021-05-25 | 개시 | Wells Fargo | Overweight |
2021-01-28 | 개시 | Truist | Buy |
2020-10-08 | 개시 | BTIG Research | Buy |
2020-09-28 | 개시 | Morgan Stanley | Overweight |
2020-09-17 | 개시 | SVB Leerink | Outperform |
2020-06-10 | 재개 | Piper Sandler | Overweight |
2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
2018-10-05 | 개시 | JP Morgan | Neutral |
2018-07-05 | 재확인 | Piper Jaffray | Overweight |
2017-08-07 | 재확인 | Morgan Stanley | Overweight |
2016-11-10 | 재확인 | The Benchmark Company | Buy |
2016-05-23 | 재확인 | The Benchmark Company | Buy |
2016-05-11 | 재확인 | The Benchmark Company | Buy |
2016-04-19 | 개시 | The Benchmark Company | Buy |
2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2015-08-04 | 개시 | Robert W. Baird | Outperform |
2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
2015-07-27 | 개시 | Piper Jaffray | Overweight |
2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
What analysts say about Natera Inc. stockTriple-digit growth rates - PrintWeekIndia
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
What institutions are buying Natera Inc. stock nowHigh-yield capital appreciation - jammulinksnews.com
Natera CFO Brophy sold $303k in NTRA stock - Investing.com Australia
Natera's Prospera™ Heart with DQS: A Game-Changer in Transplant Monitoring - AInvest
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT - Yahoo Finance
Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com Australia
Natera CEO Chapman sells $225,928 in shares - Investing.com
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
What drives Natera Inc. stock priceMarket-beating returns - jammulinksnews.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Natera director Sheena Jonathan sells $460k in stock By Investing.com - Investing.com Nigeria
Natera director Sheena Jonathan sells $460k in stock - Investing.com
Natera(NTRA) Shares Plunge 3.12% Amid Market, Regulatory Challenges - AInvest
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera(NTRA) Shares Plunge 9.16% Amid Regulatory Hurdles - AInvest
What makes Natera Inc. stock price move sharplySafety First Trading Signals - beatles.ru
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera's $234M Trading Volume Ranks 433rd Amid Market Challenges - AInvest
Special master to decide whether Quinn Emanuel lawyers must contribute to $3M sanction - ABA Journal
Natera, Inc. (NTRA): A Bull Case Theory - Insider Monkey
Is Natera (NASDAQ:NTRA) Using Too Much Debt? - 富途牛牛
Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters
Mike Brophy is regarded as one of Austin's best CFOs - The Business Journals
Natera's 'Signatera' detects recurrence of cancer through a blood test - Fox Business
Natera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Natera Rings the Opening Bell - Nasdaq
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natera Inc 주식 (NTRA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Jul 24 '25 |
Sale |
139.50 |
755 |
105,320 |
70,494 |
Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Jul 23 '25 |
Sale |
141.28 |
495 |
69,934 |
71,249 |
자본화:
|
볼륨(24시간):